Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-19T01:13:39.319Z Has data issue: false hasContentIssue false
  • English
  • Français

Longitudinal relationship between expressed emotion and cannabis misuse in young people with first-episode psychosis

Published online by Cambridge University Press:  15 April 2020

C. González-Blanch ,
J.F. Gleeson ,
S.M. Cotton ,
K. Crisp ,
P.D. McGorry  and
M. Alvarez-Jimenez
C. González-Blanch*
Affiliation:
Mental Health Centre, University Hospital “Marqués de Valdecilla”, Santander, Spain
J.F. Gleeson
Affiliation:
School of Psychology, Australian Catholic University, Melbourne, Australia
S.M. Cotton
Affiliation:
Centre for Youth Mental Health, University of Melbourne, Australia Orygen Youth Health Research Centre, Melbourne, Australia
K. Crisp
Affiliation:
Orygen Youth Health, Melbourne, Australia
P.D. McGorry
Affiliation:
Centre for Youth Mental Health, University of Melbourne, Australia Orygen Youth Health Research Centre, Melbourne, Australia
M. Alvarez-Jimenez
Affiliation:
Centre for Youth Mental Health, University of Melbourne, Australia Orygen Youth Health Research Centre, Melbourne, Australia
*
*Corresponding author. Hospital Universitario “Marqu's de Valdecilla”, Unidad de Investigaciόn en Psiquiatría de Cantabria, Planta 2a, Edificio 2 de Noviembre. Avda. Valdecilla s/n, 39008 Santander, Spain. Tel.: +34942202537; fax: +34942203447.E-mail address:[email protected] (C. González-Blanch).
Get access

Abstract

Carers’ expressed emotion (EE) and patients’ cannabis misuse are two of the most robust predictors of psychotic relapse. We aimed to examine the temporal relationship between EE and cannabis misuse. Sixty-three key carers of young people with first-episode psychosis (FEP) were assessed at baseline and 7-month follow-up. EE was measured in carers using the Family Questionnaire (FQ) and cannabis misuse in patients using the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Correlational and hierarchical logistic regression analyses were conducted to examine the temporal relationship between EE components (i.e. criticism and emotional over involvement) and cannabis misuse. Carers’ criticism at baseline significantly predicted cannabis misuse according to the ASSIST at 7-month follow-up. The association remained significant after controlling for baseline symptom severity and social functioning (B = 0.15, P = .02). Conversely, baseline cannabis misuse was not associated with carers’ criticism at 7-month follow-up. Patients in families with high criticism showed a tendency to increase cannabis misuse over time whereas the opposite trend was observed in those with carers with low criticism. A family environment characterized by high criticism may become a key risk factor for worsening cannabis misuse over time in young people with FEP. Further studies should investigate the potential mechanisms (e.g., patient's anxiety or perceived stress) through which criticism increases cannabis misuse in FEP.

Keywords

Expressed emotionCannabisFirst-episode psychosisSchizophreniaFamiliesCriticism
Type
Original article
Information
European Psychiatry , Volume 30 , Issue 1 , January 2015 , pp. 20 - 25
Copyright
Copyright © Elsevier Masson SAS 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addington, J, Addington, D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand 2007;115:304–309.CrossRefGoogle ScholarPubMed
Alvarez-Jimenez, M, Gleeson, JF, Cotton, S, Wade, D, Gee, D, Pearce, T, et al.Predictors of adherence to cognitive-behavioural therapy in first-episode psychosis. Can J Psychiatry 2009;54:710–718.CrossRefGoogle ScholarPubMed
Alvarez-Jimenez, M, Gleeson, JF, Cotton, SM, Wade, D, Crisp, K, Yap, MB, et al.Differential predictors of critical comments and emotional over-involvement in first-episode psychosis. Psychol Med 2010;40:63–72.CrossRefGoogle ScholarPubMed
Alvarez-Jimenez, M, Parker, AG, Hetrick, SE, McGorry, PD, Gleeson, JF. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr Bull 2011;37:619–630.CrossRefGoogle ScholarPubMed
Alvarez-Jimenez, M, Priede, A, Hetrick, SE, Bendall, S, Killackey, E, Parker, AG, et al.Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res 2012;139:116–128.CrossRefGoogle ScholarPubMed
Andreasen, NCScale for the Assessment of Negative Symptoms (SANS). Iowa City, IA: University of Iowa; 1984.Google Scholar
APA, Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition DSM-IVWashington, DC: American Psychiatric Press; 1994.Google Scholar
Archie, S, Boydell, KM, Stasiulis, E, Volpe, T, Gladstone, BM. Reflections of young people who have had a first episode of psychosis: what attracted them to use alcohol and illicit drugs?. Early Interv Psychiatry 2013;7:193–199.CrossRefGoogle ScholarPubMed
Butzlaff, RL, Hooley, JM. Expressed emotion and psychiatric relapse: a meta-analysis. Arch Gen Psychiatry 1998;55:547–552.CrossRefGoogle ScholarPubMed
Cannon-Spoor, HE, Potkin, SG, Wyatt, RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982;8:470–484.CrossRefGoogle ScholarPubMed
Clausen, L, Hjorthoj, CR, Thorup, A, Jeppesen, P, Petersen, L, Bertelsen, M, et al.Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial. Psychol Med 2013 1–10.Google ScholarPubMed
Cotton, SM, McCann, TV, Gleeson, JF, Crisp, K, Murphy, BP, Lubman, DI. Coping strategies in carers of young people with a first episode of psychosis. Schizophr Res 2013;146:118–124.CrossRefGoogle ScholarPubMed
Charles, V, Weaver, T. A qualitative study of illicit and non-prescribed drug use amongst people with psychotic disorders. J Ment Health 2010;19:99–106.CrossRefGoogle ScholarPubMed
First, M, Spitzer, R, Williams, J, Gibbon, MStructured clinical interview for DSM-IV axis II personality disorders (SCID-II) user's guide and interview. Washington, DC: American Psychiatric Press; 1997.Google Scholar
Fritz, CO, Morris, PE, Richler, JJ. Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen 2012;141:2–18.CrossRefGoogle ScholarPubMed
Ginsberg, JWechsler test of adult reading. Appl Neuropsychol 2003 182–184.CrossRefGoogle Scholar
Gleeson, JF, Cotton, SM, Alvarez-Jimenez, M, Wade, D, Crisp, K, Newman, B, et al.Family outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis. J Clin Psychiatry 2010;71:475–483.CrossRefGoogle ScholarPubMed
Gleeson, JF, Cotton, SM, Alvarez-Jimenez, M, Wade, D, Gee, D, Crisp, K, et al.A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. J Clin Psychiatry 2009;70:477–486.CrossRefGoogle ScholarPubMed
Gleeson, JF, Cotton, SM, Alvarez-Jimenez, M, Wade, D, Gee, D, Crisp, K, et al.A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients: outcome at 30-month follow-up. Schizophr Bull 2013;39:436–448.CrossRefGoogle ScholarPubMed
Goldman, HH, Skodol, AE, Lave, TR. Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 1992;149:1148–1156.Google ScholarPubMed
Gonzalez-Pinto, A, Alberich, S, Barbeito, S, Gutierrez, M, Vega, P, Ibanez, B, et al.Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull 2011;37:631–639.CrossRefGoogle ScholarPubMed
Green, B, Kavanagh, DJ, Young, RM. Reasons for cannabis use in men with and without psychosis. Drug Alcohol Rev 2004;23:445–453.CrossRefGoogle ScholarPubMed
Gregg, L, Barrowclough, C, Haddock, G. Reasons for increased substance use in psychosis. Clin Psychol Rev 2007;27:494–510.CrossRefGoogle ScholarPubMed
Gregg, L, Haddock, G, Barrowclough, CSelf-reported reasons for substance use in schizophrenia: a Q-methodological investigation. Mental health and substance use. 2009 24–39.CrossRefGoogle Scholar
Hides, L, Cotton, SM, Berger, G, Gleeson, J, O’Donnell, C, Proffitt, T, et al.The reliability and validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in first-episode psychosis. Addict Behav 2009;34:821–825.CrossRefGoogle Scholar
Hides, L, Dawe, S, Kavanagh, DJ, Young, RM. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study. Br J Psychiatry 2006;189:137–143.CrossRefGoogle ScholarPubMed
Hooley, JM. Expressed emotion and relapse of psychopathology. Annu Rev Clin Psychol 2007;3:329–352.CrossRefGoogle ScholarPubMed
Kazarian, SS, Malla, AK, Cole, JD, Baker, B. Comparisons of two expressed emotion scales with the Camberwell family interview. J Clin Psychol 1990;46:306–309.3.0.CO;2-2>CrossRefGoogle ScholarPubMed
King, S, Dixon, MJ. Expressed emotion and relapse in young schizophrenia outpatients. Schizophr Bull 1999;25:377–386.CrossRefGoogle ScholarPubMed
Kolliakou, A, Joseph, C, Ismail, K, Atakan, Z, Murray, RM. Why do patients with psychosis use cannabis and are they ready to change their use?. Int J Dev Neurosci 2011;29:335–346.CrossRefGoogle ScholarPubMed
Koskinen, J, Lohonen, J, Koponen, H, Isohanni, M, Miettunen, J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 2010;36:1115–1130.CrossRefGoogle ScholarPubMed
Kuipers, E, Bebbington, P, Dunn, G, Fowler, D, Freeman, D, Watson, P, et al.Influence of carer expressed emotion and affect on relapse in non-affective psychosis. Br J Psychiatry 2006;188:173–179.CrossRefGoogle ScholarPubMed
Linszen, DH, Dingemans, PM, Nugter, MA, Van der Does, AJ, Scholte, WF, Lenior, MA. Patient attributes and expressed emotion as risk factors for psychotic relapse. Schizophr Bull 1997;23:119–130.CrossRefGoogle ScholarPubMed
Lobbana, F, Barrowclough, C, Jeffery, S, Bucci, S, Taylor, K, Mallinson, S, et al.Understanding factors influencing substance use in people with recent onset psychosis: a qualitative study. Soc Sci Med 2010;70:1141–1147.CrossRefGoogle ScholarPubMed
Lukoff, D, Liberman, RP, Nuechterlein, KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull 1986;12:578–602.CrossRefGoogle ScholarPubMed
Montgomery, SM. Depressive symptoms in acute schizophrenia. Prog Neuropsychopharmacol 1979;3:429–433.CrossRefGoogle ScholarPubMed
Mueser, KT, Drake, RE, Wallach, MA. Dual diagnosis: a review of etiological theories. Addict Behav 1998;23:717–734.CrossRefGoogle ScholarPubMed
Newcombe, DA, Humeniuk, RE, Ali, R. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug Alcohol Rev 2005;24:217–226.CrossRefGoogle ScholarPubMed
Portney, LG, Watkins, MPFoundations of clinical research: applications to practice. 2nd ed.NJ: Prentice-Hall, Upper Saddle River; 2000.Google Scholar
Pourmand, D, Kavanagh, DJ, Vaughan, KExpressed emotion as predictor of relapse in patients with comorbid psychoses and substance use disorder. Aust N Z J Psychiatry 2005;39:473–478.CrossRefGoogle ScholarPubMed
Regier, DA, Farmer, ME, Rae, DS, Locke, BZ, Keith, SJ, Judd, LL, et al.Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511–2518.CrossRefGoogle ScholarPubMed
Rothman, KJNo adjustments are needed for multiple comparisons. Epidemiology 1990;1:43–46.CrossRefGoogle ScholarPubMed
Spencer, C, Castle, D, Michie, PTMotivations that maintain substance use among individuals with psychotic disorders. Schizophr Bull 2002;28:233–247.CrossRefGoogle ScholarPubMed
Vaughn, C, Leff, JThe measurement of expressed emotion in the families of psychiatric patients. Br J Soc Clin Psychol 1976;15:157–165.CrossRefGoogle ScholarPubMed
WHO. ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction 2002;97:1183–1194.CrossRefGoogle Scholar
Wiedemann, G, Rayki, O, Feinstein, E, Hahlweg, KThe family questionnaire: development and validation of a new self-report scale for assessing expressed emotion. Psychiatry Res 2002;109:265–279.CrossRefGoogle ScholarPubMed
Wisdom, JP, Manuel, JI, Drake, RESubstance use disorder among people with first-episode psychosis: a systematic review of course and treatment. Psychiatr Serv 2011;62:1007–1012.CrossRefGoogle ScholarPubMed
Zammit, S, Moore, TH, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, et al.Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry 2008;193:357–363.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.